You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) – Abreos Biosciences today announced a collaboration with ResearchDx to make a test for monitoring Tysabri (natalizumab) available to clinicians and clinical trial partners.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.